Targeting wildtype and L858R/T790M mutant EGFR by isoliquiritigenin induces apoptosis and Inhibits tumor growth of NSCLC

被引：0
|
作者：
Lee, Mee-Hyun [1 ]
Jung, Sung Keun [2 ]
Lim, Do Young [3 ]
Cho, Yong-Yeon [1 ]
Lee, Cheol-Jung [1 ]
Song, Ji-Hong [1 ]
Kim, Myoung Ok [4 ]
Kim, Sung-Hyun [4 ]
Bode, Ann M. [3 ]
Dong, Zigang [3 ]
机构：
[1] Catholic Univ Korea, Coll Pharm, Bucheon, South Korea
[2] Korea Food Res Inst, Div Metab & Funct Res, Songnam, South Korea
[3] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
[4] Kyungpook Natl Univ, Ctr Lab Anim Resources, Sch Anim BT Sci, Daegu, South Korea
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1917
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1917
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Computational studies of potent covalent inhibitors on wild type or T790M/L858R mutant epidermal growth factor receptor
    Yang, Zichao
    Yang, Haikui
    Ai, Yangcheng
    Zhang, Lishun
    Li, Zhonghuang
    Wan, Shanhe
    Xu, Xuan
    Zhang, Huiwu
    Wu, Shaoyu
    Zhang, Jiajie
    Zhang, Tingting
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 152
  • [42] The Alteration of T790M Prevalence Between 19 Deletions and L858R in NSCLC After EGFR-TKIs Therapy, a Meta-Analysis
    Liang, H.
    Chen, D.
    He, J.
    Liang, W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1850 - S1851
  • [43] Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping
    Juchum, Michael
    Guenther, Marcel
    Doering, Eva
    Sievers-Engler, Adrian
    Laemmerhofer, Michael
    Laufer, Stefan
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (11) : 4636 - 4656
  • [44] A High-throughput Cell-based Screening for L858R/T790M Mutant Epidermal Growth Factor Receptor Inhibitors
    Lin, Wen-Hsing
    Song, Jen-Shin
    Lien, Tzu-Wen
    Chang, Chun-Yu
    Wu, Szu-Huei
    Huang, Yu-Wen
    Chang, Teng-Yuan
    Fang, Ming-Yu
    Yen, Kuei-Jung
    Chen, Chun-Hwa
    Chu, Chang-Ying
    Hsieh, Hsing-Pang
    Chen, Yi-Rong
    Chao, Yu-Sheng
    Hsu, John T-A
    ANTICANCER RESEARCH, 2012, 32 (01) : 147 - 151
  • [45] Potent, novel small molecule inhibitors targeting EGFR L858R/T790M mutation for non-small cell lung cancer
    Sivanandhan, Dhanalakshmi
    Parikh, Payal K.
    Sheshachalam, Avinash
    Chandregowda, V
    Bhakthavatchalam, Rajagopal
    Gupta, Manish
    Giri, Sanjeev
    Krishnakumar, V
    CANCER RESEARCH, 2014, 74 (19)
  • [46] The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis
    Liang, Hengrui
    Pan, Zhenkui
    Wang, Wei
    Guo, Chengye
    Chen, Difei
    Zhang, Jianrong
    Zhang, Yiyin
    Tang, Shiyan
    He, Jianxing
    Liang, Wenhua
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2311 - +
  • [47] Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant
    Zhou, Wei
    Liu, Xiaofeng
    Tu, Zhengchao
    Zhang, Lianwen
    Ku, Xin
    Bai, Fang
    Zhao, Zhenjiang
    Xu, Yufang
    Ding, Ke
    Li, Honglin
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (20) : 7821 - 7837
  • [48] Synthesis and preclinical evaluation of a molecular probe for imaging lung cancer with L858R/T790M mutation of epidermal growth factor receptor (EGFR)
    Fawwaz, Muammar
    Mishiro, Kenji
    Nishii, Ryuichi
    Shiba, Kazuhiro
    Kinuya, Seigo
    Ogawa, Kazuma
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [49] Correlated Motions and Dynamics in Different Domains of Epidermal Growth Factor Receptor With L858R and T790M Mutations
    Qureshi, Rizwan
    Ghosh, Avirup
    Yan, Hong
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2022, 19 (01) : 383 - 394
  • [50] Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutant
    Fukuda, Tsutomu
    Anzai, Mizuho
    Nakahara, Akane
    Yamashita, Kentaro
    Matsukura, Kazuaki
    Ishibashi, Fumito
    Oku, Yusuke
    Nishiya, Naoyuki
    Uehara, Yoshimasa
    Iwao, Masatomo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 34
12345